-
The Use of Dynamic Models in Economic Evaluations in the UK and France
Sep 9, 2025, 16:22 PM -
Director Primary Data Collection
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of Biosimilars in Europe: A Cost Analysis of Infliximab, Trastuzumab, and Rituximab
Sep 9, 2025, 16:22 PM -
Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy
Sep 9, 2025, 16:22 PM -
Citizens’ Send Messages to Policy Makers Related to Primary Healthcare Practices: First Results From the Implementation of the Patient-Reported Indicator Surveys PaRIS in Greece
Sep 9, 2025, 16:22 PM -
Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab for the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC) That Expresses High Levels of PD-L1 in Türkiye
Sep 9, 2025, 16:22 PM -
A Layered Approach to Reducing Hallucinations in LLMs for Structured and Unstructured Clinical Data
Sep 9, 2025, 16:22 PM -
A Review of Cost Comparisons Submitted to NICE Since the Introduction of the Proportional Approach to Technology Appraisal
Sep 9, 2025, 16:22 PM -
Effectiveness of Vonoprazan on Health-Related Quality of Life and Sleep Quality in Chinese Patients With Reflux Esophagitis: Post Hoc Analysis of the VIEW Study
Sep 9, 2025, 16:22 PM -
Modeling What Matters: The Real-World Burden of Pregnancy-Related Complications in cTTP
Sep 9, 2025, 16:22 PM -
Simulating Patient Journeys in Heart Failure to Optimize Treatment Pathways: An Agent-Based Modeling Study
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Early FGFR3 Testing in Metastatic Urothelial Carcinoma: A Finnish Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact of High-Dose Trivalent Influenza Vaccine Efluelda® in Older Adults: A Greek Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Evaluating the Budget Impact of Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) in Patients With Moderate to Severe Asthma in the Saudi Healthcare System
Sep 9, 2025, 16:22 PM -
Forecasting Uptake of Novel Drugs Used for Atopic Dermatitis in Sweden Based on Historic RWE
Sep 9, 2025, 16:22 PM -
Do The Guardrails Have Any Effect at All? An Analysis of the Impact of the 2022 FINSTG Guardrails on the German AMNOG Process
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of LGI-Flag in Austria: A Model-Based Evaluation
Sep 9, 2025, 16:22 PM -
Semaglutide Weight Outcomes Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Real-World Setting
Sep 9, 2025, 16:22 PM -
Treatment Patterns in Epithelial Ovarian Cancer (EOC) With a Focus on Recurrent EOC and PARPi Progressors: A Targeted Literature Review Across Selected Countries
Sep 9, 2025, 16:22 PM
